YELLOW FEVER TRAVEL ADVISORY AND APPROVED VACCINATION CENTRES IN MALAYSIA

Similar documents
Zika Virus. History of Zika virus

Enterprise Health Security Center Library Zika Virus: Employee Situational Update

LIMITED LIABILITY PARTNERSHIP

LIMITED LIABILITY PARTNERSHIP

Video Conferencing Service for Sabah and Sarawak Courts. VC policy. (Document Reference : SNT/VC/V3-2015)

country profiles WHO regions

West Nile Virus: Recognition, Prevention, and Control

Bangladesh Visa fees for foreign nationals

Countries Ranked by Per Capita Income A. IBRD Only 1 Category iv (over $7,185)

WEST NILE VIRUS DEPARTMENT OF HEALTH AND HUMAN SERVICES

Department of Occupational Safety and Health Ministry of Human Resources Malaysia

You are planning to travel on vacation or business does your destination require a vaccination?

Expression of Interest in Research Grant Applications

Proforma Cost for international UN Volunteers for UN Partner Agencies for International UN Volunteers (12 months)

SOGC recommendation on ZIKA virus exposure for clinicians caring for pregnant women and those who intend to get pregnant

DEFINITION OF THE CHILD: THE INTERNATIONAL/REGIONAL LEGAL FRAMEWORK. The African Charter on the Rights and Welfare of the Child, 1990

UNHCR, United Nations High Commissioner for Refugees

New i-access User Guide Investor Module

UNAIDS 2013 AIDS by the numbers

What kind of Bills can you Pay?

Township Campaign. Page 1

States Parties to the 1951 Convention relating to the Status of Refugees and the 1967 Protocol

M A L A Y S I A. Warta Kerajaan S E R I P A D U K A B A G I N D A DITERBITKAN DENGAN KUASA HIS MAJESTY S GOVERNMENT GAZETTE PUBLISHED BY AUTHORITY

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT

PROGRAM : CERTIFICATION COURSE FOR "200 HOURS TRAINING ON HAEMODIALYSIS FOR REGISTERED MEDICAL PRACTITIONERS "

Public Health Monitoring of Returning Travellers

1. Bank Draft No. Amount S$ 2. Bank Draft No. Amount S$

Immunizing Pharmacist Signature

OFFICIAL NAMES OF THE UNITED NATIONS MEMBERSHIP

I-ACCESS USER GUIDE INVESTOR MODULE GETTING STARTED

BE SURE. BE SAFE. VACCINATE.

Corporate Overview Creating Business Advantage

What kind of Bills can you Pay?

FDI performance and potential rankings. Astrit Sulstarova Division on Investment and Enterprise UNCTAD

MALAYSIA. ADMINISTRATIVE PROCEDURES FOR MEDICAL EXAMINATIONS AND MEDICAL CERTIFICATION FOR AIRCREW, ATCO s, PPL AND SPL LICENCE

Admission to UNICAMP. 1. The Undergraduate Program Regular students The vestibular examination

MINISTRY OF HEALTH PANDEMIC INFLUENZA A / H1N VACCINE FREQUENTLY ASKED QUESTIONS

COMMONWEALTH of VIRGINIA Department of Health

מדינת ישראל. Tourist Visa Table

Country Briefing: Jordan Multidimensional Poverty Index (MPI) At a Glance

Summary of GAVI Alliance Investments in Immunization Coverage Data Quality

Eligibility List 2015

International Fuel Prices 2012/2013

Quote Reference. Underwriting Terms. Premium Currency USD. Payment Frequency. Quotation Validity BUPA AFRICA PROPOSAL.

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT UPDATE

Master of Business NilaiU

Zika virus infection: guidance for primary care

INFORMATION FOR GRADUATE STUDENTS REGARDING MEDICAL CARE

E4impact & Scalability

Fiscal Rules and Fiscal Responsibility Frameworks for Growth in Emerging and Low-Income Countries

African Elephant (Loxondonta africana)

Ebola virus disease. Filoviridae: enveloped RNA viruses

Appendix A. Crisis Indicators and Infrastructure Lending

The Effective Vaccine Management Initiative Past, Present and Future

Guidelines for DBA Coverage for Direct and Host Country Contracts

Outsource International Ltd

NO. BANKS (IN ALPHABETICAL ORDER) CONTACT PERSON. 1 Affin Bank Berhad / Affin Islamic Bank Berhad. At domicile branch where account is maintained.

What Can I Do With the Data?

SPRINT CALL HOME PREPAID CALLING CARD

Travel to Africa David V. Diamond, MD MIT Medical Department

IMPORTANT: PLEASE READ

SYNERGY CARDS SDN BHD

Frequently asked questions for malaria

MEETING THE INVESTMENT CHALLENGE TIPPING THE DEPENDENCY BALANCE

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

INSTRUCTIONS FOR COMPLETING THE USAID/TDA DEFENSE BASE ACT (DBA) APPLICATION

Per Minute Rate Unlimited North America

BADEA EXPORT FINANCING SCHEME (BEFS) GUIDELINES

CONTENTS THE UNITED NATIONS' HIGH COMMISSIONER FOR REFUGEES (UNHCR)

COMMISSION IMPLEMENTING DECISION. of

msos Mobile SMS-based disease outbreak alert system

West Nile Virus and Workers

The applicants can submit the eligibility form from 07/01/2016 to 07/02/2016. For additional information, please contact:

Libreville Declaration on Health and Environment in Africa

GLOBAL Country Well-Being Rankings. D Social (% thriving) E Financial (% thriving) F Community (% thriving) G Physical (% thriving)

Global Fuel Economy Initiative Africa Auto Club Event Discussion and Background Paper Venue TBA. Draft not for circulation

West Nile Virus Encephalitis Fact Sheet

LOGISTICAL INFORMATION FOR DELEGATES

New Zealand =============================== Standard Courier NZD$5.00 Rural Delivery Courier NZD $ $4.50 = $9.50. Australia (Zona A)

HEALTH HISTORY & IMMUNIZATION FORM

Adobe Creative Cloud Availability

Action required The Committee is requested to take note of the position of income and expenditure as of 30 September 2010.

EBOLA SITUATION REPORT

1. RUMAH ORANG-ORANG TUA UZUR PULAU PINANG NO.409, JALAN MASJID NEGERI PENANG TELL : (MR.OH/ MR.OOI)

Entrance Visas in Brazil (Updated on November, 24, 2015)

Entrance Visas in Brazil (Updated on July 08, 2014)

Dengue in the WHO european region

KIGALI DECLARATION ON THE DEVELOPMENT OF AN EQUITABLE INFORMATION SOCIETY IN AFRICA

EMERGENCIES 911 ABROAD

PROFILE Y AN OMP C C O M P A N Y P R O F I L E

Sentinel Chicken Screening Here are the mosquito larvae! Ground Application Aerial Larvicide Applications

H1N1 Vaccine Deployment and Vaccination update

AFR EUR MENA NAC SACA SEA WP

EP Waterproofing System - Projects

EXPLORER HEALTH PLAN. Product Summary From 1 September bupa-intl.com. Insured by Working with Brokered by

LIST OF PAYMENT FOR VISA AND SECURITY BOND PAYMENT FOR VISA ( RM )

Tdap and MenC booster vaccines. Information for parents of children in First Year of second level school

Lebara Unlimited Plan

Goal 6: Combat HIV/AIDS, malaria and other diseases

1.1 LIST OF DAILY MAXIMUM AMOUNT PER COUNTRY WHICH IS DEEMED TO BEEN EXPENDED

Transcription:

YELLOW FEVER TRAVEL ADVISORY AND APPROVED VACCINATION CENTRES IN MALAYSIA INTRODUCTION Yellow fever is an acute infectious disease. Recognised in two different forms i.e. urban and jungle Yellow fever. Urban Yellow fever occurs in cities and is spread from mosquito to human. In the jungle form, Yellow fever is spread from mosquitoes to monkeys and also to humans (zoonosis). Although reported cases of human disease is the principal indicator of disease risk, they may be absent (because of a high level of immunity in population) or not detected as a result of poor surveillance. Yellow fever is a major public health threat in countries with risk of Yellow fever transmission. Travellers to countries with risk of Yellow fever transmission in Africa, Central and South America are at risk. The presence of the suitable vector, Aedes mosquito in Asia may contribute to its potential occurrence. Malaysia is vulnerable to risk of Yellow fever transmission because of the presence of the Aedes mosquito vector. Causative agent: Arbovirus of the Genus Flavivirus and family Flaviviridae. Mode of Transmission: through the bite of infective Aedes aegypti mosquitoes. Incubation Period: 3-6 days (or longer) after the bite of an infected mosquito. COUNTRIES WITH RISK OF YELLOW FEVER TRANSMISSION SOUTH & CENTRAL AMERICA (13 COUNTRIES) Argentina French Guiana Suriname Brazil Guyana Trinidad & Tobago Bolivia Panama Venezuela Colombia Ecuador Paraguay Peru

AFRICA (30 COUNTRIES) Angola Benin Burkina Faso Burundi Cameroon Central Africa Republic Chad Congo Democratic Republic Of Congo Ethiopia Gabon Gambia Ghana Guinea Guinea Bissau Guinea Equatorial Ivory Coast Kenya Liberia Mali Mauritania Niger Nigeria Rwanda Senegal Sierra Leone Sudan South Sudan Togo Uganda Note: The list of countries with risk of yellow fever transmission is updated based on WHO list. SIGN & SYMPTOMS Some are asymptomatic but most lead to an acute illness characterized by two phases. Initially there is fever, muscular pain, headache, chills, anorexia, nausea and/or vomiting, often with bradycardia. About 15% of patients progress to a second phase after a few days, with resurgence of fever, development of jaundice, abdominal pain, vomiting and haemorrhagic manifestations. Death may occur 10-14 days after the onset of illness.

COMPLICATIONS Haemorrhagic manifestation including epistaxis, gingival bleeding, hematemesis (coffee ground or black), melena, and liver and renal failure. Up to 50% are fatal. TREATMENT Symptomatic treatment. Advise rest, drink plenty of fluids and take regular painkillers (e.g. Paracetamol or Ibuprofen) to relieve symptoms of fever or aching. Specific treatment None PREVENTION & PRECAUTIONS Yellow Fever Vaccination Requirement A Yellow fever vaccination certificate is required from all visitors or delegates (Malaysians and Foreigners) coming from or going to/through countries with risk of Yellow fever transmission. (As per International Health Regulations 2005 and Prevention and Control of Infectious Diseases Act 1988). Yellow fever vaccination is also required for travellers having transited more than 12 hours through the airport of a country with risk of yellow fever transmission; Travellers or delegates without a valid Yellow fever vaccination certificate shall be quarantined upon arrival in Malaysia for a period not exceeding 6 days. The period of validity of an international certificate of vaccination against Yellow fever is valid for life, beginning 10 days after the date of vaccination (beginning June 2016). The period of validity of an international certificate of vaccination against Yellow fever is 10 years, beginning 10 days after the date of vaccination. Note: The WHO World Health Assembly in May 2014 adopted an amendment to Annex 7 of the International Health Regulations (2005) (IHR), which stipulates that the period of protection afforded by yellow fever vaccination, and the term of validity of the certificate will change from 10 years to the duration of the life of the person vaccinated. This change will enter into force legally in June 2016. Until then the current IHR text on yellow fever vaccination and certificates continues to apply, and some countries may continue to request proof of vaccination or a booster within the last 10 years from travellers. (WHO International travel and health: http://www.who.int/ith/updates/20140605/en/).

Reminder to Malaysians travelling to Countries with Risk of Yellow Fever Transmission Malaysians are advised to take the vaccination against Yellow fever at least 10 days before the date of departure to countries with risk of Yellow fever transmission for protection against infection. To get the vaccination against Yellow fever at the approved Yellow fever vaccination centres in Malaysia. To carry the international certificate of vaccination during travel for health check. To report to Point of Entry Health Office on arrival in Malaysia for health check. YELLOW FEVER VACCINE Type of vaccine: Live attenuated vaccine Number of doses: One dose of 0.5ml Contraindications: Infants aged less than 6 months; history of severe allergy to egg or to any of the vaccine components, or hypersensitivity to a previous dose of the vaccine; thymoma or history of thymectomy, immunodeficiency from medication, disease or symptomatic HIV infection Adverse reactions: Rarely, neurological (encephalitis) or multi-organ failure resembling wild-type yellow fever. Before departure: International certificate of vaccination becomes valid 10 days after vaccination. Recommended for: All travellers to countries and areas with risk of yellow fever transmission and when required by countries. Special precautions: Not recommended for infants aged 6 8 months, except during epidemics when the risk of YF virus transmission may be very high. The risks and benefits of vaccination in this age group should be carefully considered before vaccination. The vaccine should be avoided during pregnancy or breastfeeding. However, pregnant or nursing women may be vaccinated during epidemics or if travel to a country or area at risk of transmission is unavoidable. (Reference: WHO International Travel & Health Yellow fever vaccine (URL: http://www.who.int/ith/vaccines/yf/en/ accessed 15 March 2015)

LIST OF APPROVED YELLOW FEVER VACCINATION CENTRES IN MALAYSIA (until March 2015) 1. Pejabat Kesihatan Pelabuhan Pulau Pinang 1 st Floor, Tuanku Syed Putra Building Jalan Downing, 10300 Pulau Pinang. Tel: 04-2611264, 04-2644918 2. BP Diagnostic Centre 275, Jalan Kampar 30250 Ipoh, Perak Tel: 05-2559090 Ext 402 3. Klinik Kesihatan Jelapang (Pejabat Kesihatan Kinta) Jalan Jelapang 30010, Ipoh, Perak. Tel: 05-5286158, Fax. 05-5272355 4. Klinik Berkat No. 75-4A, Jalan Mamanda 1, Ampang Point 68000 Ampang, Selangor Darul Ehsan Tel: 03-42515450 5. KPJ Selangor Specialist Hospital Lot 1, Jalan Singa 20/1 Section 20, 40300 Shah Alam Tel: 03-5543 1111, Fax: 03-5543 1722 6. Klinik Noridah VG 30, Jalan Plumbum V7/V Pusat Komersial Seksyen 7 40000 Shah Alam Tel: 03-5510 1009 Fax: 03-5510 1009 7. Klinik Mediviron No. 20 A, Jalan Jubli Perak 22/1 Seksyen 22, 40300 Shah Alam, Selangor Tel: 03-5567 9667 Fax: 03-5567 9667 PULAU PINANG PERAK PERAK SELANGOR SELANGOR SELANGOR SELANGOR 8. BP Specialist Centre Taman Megah Branch No. 79, Jalan SS 23/15, Taman SEA

LIST OF APPROVED YELLOW FEVER VACCINATION CENTRES IN MALAYSIA (until March 2015) 47400 Petaling Jaya Selangor 9. Poliklinik Sri Permai No. 11, Jalan P9 B/1 Presint 9, 62259 Putrajaya Tel: 03-88880268 10 Klinik Kesihatan Putrajaya No. 1, Jalan P9E, Presinct 9 62250, Putrajaya. Tel: 03-88883057 11. Virus Research Division 1 st Floor, Institute of Medical Research Jalan Pahang, 50588 Kuala Lumpur. Tel: 03-26986033 12. The KL Clinic Mezzanine Floor, East Wing Rohas Perkasa, No. 9, Jalan P. Ramlee 50250 Kuala Lumpur 03-21660395 Faks 03-2181 3362 13. Twin Towers Medical Centre KLCC Sdn. Bhd. KLCC, Lot LC 402-404, Level 4 Suria KLCC, KL City Centre 50088, Kuala Lumpur. Tel: 03-23823500, 03-23823577 14. Klinik Kita Lot F-23, First Floor City Point Kompleks Daya Bumi Jalan Sultan Hishamuddin, 50050, Kuala Lumpur. Tel: 03-26989740, 03-26980740 15 Hospital Angkatan Tentera Tuanku Mizan (Bhg. Kesihatan Primer untuk anggota tentera sahaja) No. 3, Jalan 4/27A, Section 2, Wangsa Maju, 53300 Kuala Lumpur Tel: 03-4145 4200 SELANGOR PUTRAJAYA PUTRAJAYA

LIST OF APPROVED YELLOW FEVER VACCINATION CENTRES IN MALAYSIA (until March 2015) 16. Klinik Yong Tingkat 2, Wisma Maran No. 28, Medan Pasar 50050 Kuala Lumpur Tel; 03-20720808, Fax 03-20310487 17. Drs Young Newton dan Rakan-Rakan LEVEL 5, Capital Square, Jln Munshi Abdullah Menara Multi-purpose 50100 Kuala Lumpur. Tel: 03 26982967 18. Prince Court Medical Centre Sdn. Bhd. 39, Jalan Kia Peng 50450, Kuala Lumpur Tel: 03-21600000 ext 2984/3860 19. Klinik Integral Occupational Health Services Sdn. Bhd. Lot 2-05, Level 2 Menara HLA No. 3 Jalan Kia Peng 50450, Kuala Lumpur Tel: 03-21712882, Faks: 03-21712992 20. Gleneagles Intan Medical Centre Lot 286, Jalan Ampang 50450 Kuala Lumpur Tel: 03-41413135, Faks 03-42552980 21. Kuala Lumpur Sports Centre Sdn. Bhd. 7th Floor, Wisma Perintis Jalan Dungun, Damansara Heights 50490 Kuala Lumpur Tel: 03-20961033 Fax: 03-20961500 22. Pantai Medical Centre Sdn. Bhd. No. 8, Jalan Bukit Pantai 59100 Kuala Lumpur Tel: 03-2296 0888 Fax: 03-2282 1557

LIST OF APPROVED YELLOW FEVER VACCINATION CENTRES IN MALAYSIA (until March 2015) 23. Pusat Perubatan Menara Sdn. Bhd. Level 26, Menara TM Annexe 2 No. 1, Jalan Pantai Jaya Off Jalan Pantai Baharu 59200 Kuala Lumpur Tel: 03-2241 4101 Fax: 03-2241 4102 24. Berkat Sentral Clinic (BSC) G11 G12 Ground Floor Platinum Sentral, Jalan Stesen 2 50470 Kuala Lumpur 25. Pejabat Kesihatan Johor Bahru Jalan Abu Samad, 80100 Johor Bahru, Johor. Tel: 07-2224711, 07-2224818 26. Poliklinik Komuniti Beserah Jalan Beserah, 26100, Kuantan Negeri Pahang Darul Makmur Tel: 09-5445633 27. Health Office Divisional Health Department Kuching Division, Jalan Tun Zaidi Adruce 93150, Kuching, Sarawak. Tel: 082-432563 28. Health Office Divisional Health Department Sibu Division, 5 th Floor Wisma Persekutuan, Block 3 Persiaran Brooke, 96000 Sibu, Sarawak. Tel: 084-315494 29. Columbia Asia Medical Centre Lot 1035-1039 Jalan Bulan Sabit, CDT 155 98009, Miri, Sarawak. Tel: 085-437755 JOHOR PAHANG 30. Klinik Cheu SB Lot 512, Pelita Commercial Centre

LIST OF APPROVED YELLOW FEVER VACCINATION CENTRES IN MALAYSIA (until March 2015) 98000, Miri Sarawak Tel: 085-438068, Fax: 085-43807 31. Columbia Asia 21st Century Healthcare Lot 3582, Block 26, Jalan Sri Ikhwan Kemena Land District Tanjung Kidurong 97000 Bintulu, Sarawak Tel: 086-251888 Faks 086-252888 32. Bintulu Medical Centre Lot 6009, Block 31, Kemena Land District 97000 Bintulu, Sarawak. Tel: 086-330333 Faks 086-330777 33. Normah Medical Specialist Centre Section 30 KTLD Jalan Tun Abdul Rahman, Petra Jaya 93050, Kuching, Sarawak Tel: 082-440055 Fax: 082-442600 34. Klinik Kesihatan Luyang Off, Jalan Lintas, 88300 Luyang, Kota Kinabalu, Sabah Tel: 088-715000 35. Klinik Kesihatan Sandakan KM 3.2 Jalan Utara 90500 Sandakan, Sabah Tel: 089-225800 36. Klinik Kesihatan Apas Balung Batu 24, Jalan Apas 91008 Tawau, Sabah Tel: 089-951029 37. Klinik Wilayah (L) Sdn. Bhd. U0391, Jalan Bunga Rambai 87069 Labuan Tel: 087-413140 Fax:087-413146 SABAH SABAH SABAH WP LABUAN

PREVENTION OF MOSQUITO BITES Minimize exposure by modifying activities to avoid exposure to vector bites. Peak biting times for Aedes mosquitoes are a few hours before dusk and after dawn. Avoid outdoor activity during these periods. Avoid mosquito bite by applying mosquito repellent to exposed skin. When using sunscreen or lotions, apply repellants last. Reapply whenever sweat or water has removed it. Active ingredient in a repellent repels but does not kill insects. Repellent that contains DEET (N, N-diethylmetatoluamide) is most reliable and long-lasting type (35% DEET provides protection for 12 hours). DEET formulations as high as 50% are recommended for both adults (including pregnant women) and children more than two (2) months of age. It is toxic when ingested and may cause skin irritation. Permethrin is highly effective both as an insecticide and as a repellent. There is little potential for toxicity from Permethrintreated clothing. Use long sleeved clothes and long pants. Avoid wearing dark colours (attract mosquitoes). Close windows or shutters at night when indoors. Use pyrethrum insecticide spray (aerosol insecticides), pyrethroid coils or insecticide impregnated tablets in evening before sleep. Avoid strong perfumes, hair sprays or after-shaves (attract mosquitoes)! Use air-conditioning or good mosquito net especially treated with Permethrin. REFERENCES/RESOURCES: International Health Regulations, 2005, WHO WHO International Travel & Health, 2014 Control of Communicable Diseases Manual, 18th Edition by David L. Heymann, MD, Editor, 2004 http://www.cdc.gov/yellowfever/ http://www.travelhealth.co.uk/ Prepared by: International Health Sector Disease Control Division Ministry of Health, Malaysia Date: 15 March 2015